Shield Therapeutics plc Stock OTC Markets
Stocks
SHIEF
GB00BYV81293
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
19:37:09 11/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0704 USD | +26.16% |
|
+26.16% | -51.78% |
| 07-31 | WINNERS & LOSERS: NARF has contract cancelled; Headlam reviews options | AN |
| 07-30 | EARNINGS AND TRADING: Zoo Digital revenue falls but loss narrows | AN |
| Market Cap | 47.08M 63.74M 55.05M 51.8M 88.54M 6.11B 89.84M 608M 238M 3.05B 239M 234M 10.17B | P/E 2026 * |
-200x | P/E 2027 * | 5.96x |
|---|---|---|---|---|---|
| Enterprise Value | 65.4M 88.55M 76.48M 71.96M 123M 8.48B 125M 844M 331M 4.24B 332M 325M 14.13B | EV / Sales 2026 * |
1.16x | EV / Sales 2027 * | 0.77x |
| Free-Float |
38.25% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Shield Therapeutics plc
| 1 day | +26.16% | ||
| 1 week | +26.16% | ||
| Current month | +21.38% | ||
| 1 month | -11.22% | ||
| 3 months | -41.38% | ||
| 6 months | -52.77% | ||
| Current year | -51.78% |
| 1 month | 0.05 |  | 0.08 |
| Current year | 0.05 | | 0.17 |
| 1 year | 0.05 | | 0.17 |
| 3 years | 0.01 | | 0.17 |
| 5 years | 0.01 | | 0.64 |
| 10 years | 0.01 | | 2.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Karl Lundström
CEO | Chief Executive Officer | 64 | 24/07/2024 |
Stephanie Hicks
IRC | Investor Relations Contact | - | - |
| General Counsel | - | 01/01/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 68 | 01/02/2016 | |
| Chairman | 70 | 18/06/2020 | |
| Director/Board Member | 59 | 26/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +26.16% | +26.16% | - | - | 63.82M | |
| +0.65% | +1.66% | +41.18% | -0.27% | 80.48B | |
| -1.10% | -2.42% | -3.61% | +28.98% | 50.63B | |
| +0.88% | -3.47% | +12.88% | +166.89% | 47.57B | |
| +17.25% | +17.36% | -41.63% | -41.46% | 45.84B | |
| +1.63% | +4.25% | +56.39% | -18.61% | 30.9B | |
| -2.33% | +3.95% | +124.14% | -38.04% | 25.73B | |
| -0.02% | +1.98% | +45.40% | +92.80% | 25.03B | |
| +1.36% | -0.67% | -0.87% | +195.57% | 21.16B | |
| +1.49% | +3.15% | +69.69% | +123.80% | 16.75B | |
| Average | +4.60% | +0.07% | +33.73% | +56.63% | 38.23B | |
| Weighted average by Cap. | +2.54% | -0.61% | +26.33% | +42.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.28M 76.2M 65.81M 61.92M 106M 7.3B 107M 726M 285M 3.65B 286M 280M 12.16B | 75.86M 103M 88.71M 83.47M 143M 9.84B 145M 979M 384M 4.92B 386M 377M 16.39B |
| Net income | -72.5K -98.16K -84.78K -79.77K -136K -9.41M -138K -936K -367K -4.7M -369K -361K -15.67M | 7.86M 10.64M 9.19M 8.65M 14.78M 1.02B 15M 101M 39.75M 510M 39.95M 39.09M 1.7B |
| Net Debt | 18.32M 24.81M 21.43M 20.16M 34.46M 2.38B 34.97M 236M 92.67M 1.19B 93.14M 91.12M 3.96B | 11.13M 15.07M 13.02M 12.25M 20.94M 1.44B 21.25M 144M 56.31M 722M 56.59M 55.36M 2.41B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- STX Stock
- SHIEF Stock
Select your edition
All financial news and data tailored to specific country editions
